ArticleClinical and experimental rheumatology2026
Phosphodiesterase-5 inhibitors, but not calcium channel blockers, improve peripheral vascular function in systemic sclerosis.
Daniel R Machin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.